Associations between serum selenium and total plasma homocysteine during the acute phase of ischaemic stroke

European Neurology

Volumn 60, Issue 6, 2008, Pages 298-303

  Angelova, Evgeniya A ^a   Atanassova, Penka A ^a   Chalakova, Nedka T ^a   Dimitrov, Borislav D ^b  

^a MEDICAL UNIVERSITY OF PLOVDIV   (Bulgaria)

^b UNIVERSITY HOSPITAL ST GEORGE   (Bulgaria)

Author keywords

Cerebrovascular risk factors; Ischaemic stroke; Plasma homocysteine; Serum selenium

Indexed keywords

FIBRINOGEN; HOMOCYSTEINE; PYRIDOXINE; SELENIUM; TRIACYLGLYCEROL;

ADULT; ARTICLE; CEREBROVASCULAR ACCIDENT; CONTROL GROUP; CONTROLLED STUDY; FEMALE; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RADIODIAGNOSIS; REGRESSION ANALYSIS; RISK FACTOR;

FEMALE; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; MALE; MIDDLE AGED; PLASMA; SELENIUM; STROKE;

EID: 52549099970     PISSN: 00143022     EISSN: None     Source Type: Journal    
DOI: 10.1159/000157884     Document Type: Article

References (21)

1. Bushnell CD, Goldstein LB: Homocysteine testing in patients with acute ischemic stroke. Neurology 2002;59:1541-1546.
2. Pezzini A, Grassi M, Del Zotto E, et al: Interaction of homocysteine and conventional predisposing factors on risk of ischaemic stroke in young people: consistency in phenotype-disease analysis and genotype-disease analysis. J Neurol Neurosurg Psychiatry 2006;77:1150-1156.
3. Virtanen JK, Voutilainen S, Happonen P, et al: Serum homocysteine, folate and risk of stroke: Kuopio Ischaemic Heart Disease Risk Factor (KIHD) Study. Eur J Cardiovasc Prev Rehabil 2005;12:369-375.
4. Atanassova P, Angelova E, Tzvetanov P, Semerjieva M, Dimitrov BD: Modelling of increased homocysteine in ischaemic stroke: post-hoc cross-sectional matched case-control analysis in 82 young Bulgarian patients. Arq Neuropsiquiatr 2007;65:24-31.
5. Stoikova V, Ivanov S, Tsoncheva A: Homocysteine and pregnancy (in Bulgarian). Akush Ginekol (Sofia) 2004;43(suppl 2):36-38.
6. Tarulov Z, Tsvetkova T: Homocysteine, hyperhomocysteinemia and its clinical manifestations (in Bulgarian). Suvremenna Medicina 2001;3:26-32.
7. Alissa EM, Bahijri SM, Ferns GA: The controversy surrounding selenium and cardiovascular disease: a review of the evidence. Med Sci Monit 2003;9:RA9-RA18.
8. González S, Huerta JM, Fernández S, Patterson AM, Lasheras C: Homocysteine increases the risk of mortality in elderly individuals. Br J Nutr 2007;97:1138-1143.
9. Foster L, Sumar S: Selenium in health and disease: a review. Crit Rev Food Sci Nutr 1997;37:211-228.
10. Uthus E, Yokoi K, Davis C: Selenium deficiency in Fisher-344 rats decreases plasma and tissue homocysteine concentrations and alters plasma homocysteine and cysteine redox status. J Nutr 2002;132:1122-1128.
11. Gonzalez S, Huerta JM, Alvarez-Uria J, Fernandez S, et al: Serum selenium is associated with plasma homocysteine concentrations in elderly humans. J Nutr 2004;134:1736-1740.
12. Klapcinska B, Poprzecki S, Danch A, Sobczak A, Kempa K: Selenium levels in blood of upper Silesian population: evidence of suboptimal selenium status in a significant percentage of the population. Biol Trace Elem Res 2005;108:1-15.
13. Venn B, Grant A, Thomson C, Green T: Selenium supplements do not increase plasma total homocysteine concentrations in men and women. J Nutr 2003;133:418-420.
14. Bamford J, Sandercock P, Dennis M, Burn J, Warlow CP: A prospective study of acute cerebrovascular disease in the community: The Oxfordshire Community Stroke Project 1981-1986. Incidence, case fatality rates and overall outcome at one year of cerebral infarction, primary intracerebral and subarachnoidal haemorrhage. J Neurol Neurosurg Psychiatry 1990;53:16-22.
15. Angelova E, Minkova G, Tsvetkova T: Total plasma homocysteine in Bulgarian population measured by high-performance liquid chromatography with fluorescent detection - Comparison with fluorescence polarization immunoassay (in Bulgarian). Clin Lab 2006;52:527-533.
16. Faul F, Erdfelder E: GPOWER: a priori, posthoc and Compromise Power Analyses for MS-DOS (Computer Program, Ver. 2.0). Bonn, Department of Psychology, Bonn University, 1992.
17. Freedman J, Frei B, Welch G, Loscalzo J: Glutathione peroxidase potentiates the inhibition of platelets function by S-nitrosothiols. J Clin Invest 1995;96:394-400.
18. Upchurch G, Welch G, Fabian A, et al: Homocysteine decreases bioavailable nitric oxide by a mechanism involving glutathione peroxidase. J Biol Chem 1997;272:17012-17017.
19. Angelova E, Arabadjiiska D, Milinkova D, Panova M: Correlation between the total plasma homocysteine and selenium (in Bulgarian). Proc Concourse 'Science and Youth', Sofia, 2006, pp 3-7.
20. Mansoor MA, Bergmark C, Haswell SJ, et al: Correlation between plasma total homocysteine and copper in patients with peripheral vascular disease. Clin Chem 2000;46:385-391.
21. Vrhovski-Hebrang D, Flegar-Mestric Z, Preden-Kerekovic V, et al: Biochemical risk factors in angiographically established stenosis of cerebral arteries. Croat Med J 2002;43:696-701.